Determination and pharmacokinetic study of indirubin in rat plasma by high-performance liquid chromatography

Phytomedicine

Volumn 15, Issue 4, 2008, Pages 277-283

  Deng, X Y ^a   Zheng, S N ^a   Gao, G H ^a   Fan, G ^a   Li, F ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

High performance liquid chromatography; Indirubin; Pharmacokinetics; Rat plasma

Indexed keywords

INDIRUBIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ULTRAVIOLET RADIATION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; INDOLES; INFUSIONS, PARENTERAL; MALE; RATS; RATS, WISTAR;

RATTUS;

EID: 41049083498     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2008.01.004     Document Type: Article

References (18)

1. Adachi J., Mori Y., Matsui S., Takigami H., Fujino J., Kitagawa H., Miller III C.A., Kato T., Saeki K., and Matsuda T. Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J. Biol. Chem. 276 (2001) 31475-31478
2. Bradbury J. From Chinese medicine to anticancer drugs. Drug Discov. Today 10 (2005) 1131-1132
3. Buolamwini J.K. Cell cycle molecular targets in novel anticancer drug discovery. Curr. Pharm. Des. 6 (2000) 379-392
4. Dai F.B., Qiao C.Z., and Li L. Determination of indigo and indirubin in qingdai by HPLC. Acta Pharm. Sinica 21 (1986) 868-871
5. Hoessel R., Leclerc S., Endicott J.A., Nobel M.E., Lawrie A., Tunnah P., Leost M., Damiens E., Marie D., Marko D., Niederberger E., Tang W., Eisenbrand G., and Meijer L. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat. Cell Biol. 1 (1999) 60-67
6. Jautelat R., Brumby T., Schafer M., Briem H., Eisenbrand G., Schwahn S., Kruger M., Lucking U., Prien O., and Siemeister G. From the insoluble dye indirubin towards highly active, soluble CDK2-inhibitors. Chembiochem 6 (2005) 531-540
7. Kasahara T. Indirubin, a Chinese anti-leukaemia drug, promotes neutrophilic differentiation of human myelocytic leukaemia HL-60 cells. Br. J. Haematol. 130 (2005) 681-690
8. Kosmopoulou M.N., Leonidas D.D., Chrysina E.D., Bischler N., Eisenbrand G., Sakarellos C.E., Pauptit R., and Oikonomakos N.G. Binding of the potential antitumour agent indirubin-5-sulphonate at the inhibitor site of rabbit muscle glycogen phosphorylase b. Comparison with ligand binding to pCDK2-cyclin A complex. Eur. J. Biochem. 271 (2004) 2280-2290
9. Kunikata T., Tatefuji T., Aga H., Iwaki K., Ikeda M., and Kurimoto M. Indirubin inhibits inflammatory reactions in delayed-type hypersensitivity. Eur. J. Pharmacol. 410 (2000) 93-100
10. Liau B.C., Jong T.T., Lee M.R., and Chen S.S. LC-APCI-MS method for detection and analysis of tryptanthrin, indigo, and indirubin in daqingye and banlangen. J. Pharm. Biomed. Anal. 43 (2007) 346-351
11. Qi S.B., He G.X., and Wan Y.D. Pharmacological studies on indirubin. III. Pharmacokinetic studies on indirubin in mice. Chin. Tradit. Herb Drugs 12 (1981) 23-27
12. Ruan J.L., Zou J.H., and Cai Y.L. Studies on chemical constituents in leaf of Isatis indigotica. Chin. J. Chin. Mater. Med. 30 (2005) 1525-1526
13. Sethi G., Ahn K.S., Sandur S.K., Lin X., Chaturvedi M.M., and Aggarwal B.B. Indirubin enhances tumor necrosis factor-induced apoptosis through modulation of nuclear factor-kappa B signaling pathway. J. Biol. Chem. 281 (2006) 23425-23435
14. Suzuki K., Adachi R., Hirayama A., Watanabe H., Otani S., Watanabe Y., Leclerc S., Garnier M., Hoessel R., Marko D., Bibb J.A., Snyder G.L., Greengard P., Biernat J., Wu Y.Z., Mandelkow E.M., and Eisenbrand G. Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?. J. Biol. Chem. 276 (2001) 251-260
15. Suzuki K., Adachi R., Hirayama A., Watanabe H., Otani S., Watanabe Y., and Kasahara T. Indirubin, a Chinese anti-leukaemia drug, promotes neutrophilic differentiation of human myelocytic leukaemia HL-60 cells. Br. J. Haematol. 130 (2005) 681-690
16. Wu G.Y., and Fang F.D. Studies on the mechanism of indirubin action in the treatment of chronic granulocytic leukemia. II. Effects of indirubin on nucleic acid and protein synthesis in animal transplantable tumor cells and normal proliferating cells in vitro. Acta Acad. Med. Sinica 2 (1980) 83-87
17. Zhao P.P. Determination of indirubin by dual wavelength TLC scanner. Bull. Chin. Mater. Med. 6 (1981) 28-30
18. Zou P., and Koh H.L. Determination of indican, isatin, indirubin and indigotin in Isatis indigotica by liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom. 21 (2007) 1239-1246